CDK4 and metastatic neoplasm: Initiation of chemotherapy (capecitabine or IV chemotherapy) for treatment of metastatic disease was significantly different in patients who received 1st-line CDK4/6i versus those who received 2nd-line CDK4/6i (p-value < 0.001, Fig. 2).